The Genomics Core will provide experimental planing, scientific services and computational support for SPORE projects using DNA microarrays. The facility is contained within the UNC Genomics Core & Microarray Facility housed in the Lineberger Comprehensive Cancer Center and adjacent to the core director's lab. It maintains centralized equipment for microarray production, utilization, and analysis. The Core also produces customized microarrays and maintains libraries of long-oligos and cDNA for printing the custom microarrays. To maximize efficiency and generate consistent quality results, the Genomics Core will provide complete microarray research services to SPORE projects. Investigators will isolate RNA and submit samples. The facility will perform quality control on all samples and prepare fluorescent probes for hybridization with either in-house produced or commercial micorarrays. The Genomics Core will provides computer hardware and analysis programs to collect and pre-process raw data before being transmitted to the Bioinformatics Core for databasing and analysis. The Genomics Core will initially support three of the SPORE projects. Its use will most likely expand to other projects and development studies as needed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA106991-05
Application #
7667867
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
5
Fiscal Year
2008
Total Cost
$154,398
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Asher, Gary N; Xie, Ying; Moaddel, Ruin et al. (2017) Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers. J Clin Pharmacol 57:185-193
Gao, Xingming; Zhu, Mengyuan; Fan, Haiying et al. (2015) A fluorescent bisboronic acid compound that selectively labels cells expressing oligosaccharide Lewis X. Bioorg Med Chem Lett 25:2501-4
Keku, Temitope O; Dulal, Santosh; Deveaux, April et al. (2015) The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol 308:G351-63
Nugent, Julia L; McCoy, Amber N; Addamo, Cassandra J et al. (2014) Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas. J Proteome Res 13:1921-9
Zhu, Hongtu; Ibrahim, Joseph G; Tang, Niansheng (2014) Bayesian Sensitivity Analysis of Statistical Models with Missing Data. Stat Sin 24:871-896
Nikolaishvilli-Feinberg, Nana; Cohen, Stephanie M; Midkiff, Bentley et al. (2014) Development of DNA damage response signaling biomarkers using automated, quantitative image analysis. J Histochem Cytochem 62:185-96
Wang, Hansong; Burnett, Terrilea; Kono, Suminori et al. (2014) Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. Nat Commun 5:4613
Lin, Ja-An; Zhu, Hongtu; Mihye, Ahn et al. (2014) Functional-mixed effects models for candidate genetic mapping in imaging genetic studies. Genet Epidemiol 38:680-91
McCoy, Amber N; Araújo-Pérez, Félix; Azcárate-Peril, Andrea et al. (2013) Fusobacterium is associated with colorectal adenomas. PLoS One 8:e53653
Kang, Melissa; Edmundson, Patrick; Araujo-Perez, Felix et al. (2013) Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas. BMC Cancer 13:91

Showing the most recent 10 out of 84 publications